Allison C. Chin

1.4k total citations
18 papers, 1.1k citations indexed

About

Allison C. Chin is a scholar working on Molecular Biology, Physiology and Cancer Research. According to data from OpenAlex, Allison C. Chin has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Physiology and 3 papers in Cancer Research. Recurrent topics in Allison C. Chin's work include Telomeres, Telomerase, and Senescence (11 papers), RNA Interference and Gene Delivery (7 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Allison C. Chin is often cited by papers focused on Telomeres, Telomerase, and Senescence (11 papers), RNA Interference and Gene Delivery (7 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Allison C. Chin collaborates with scholars based in United States, Hong Kong and Japan. Allison C. Chin's co-authors include Calvin B. Harley, Sergei Gryaznov, Krisztina Pongracz, Jerry W. Shay, Brittney‐Shea Herbert, Ginelle C. Gellert, Amelia E. Hochreiter, Woodring E. Wright, Daria Zielińska and Richard H. Scheller and has published in prestigious journals such as Blood, The Journal of Immunology and Molecular and Cellular Biology.

In The Last Decade

Allison C. Chin

18 papers receiving 1.0k citations

Peers

Countries citing papers authored by Allison C. Chin

Since Specialization

Citations

This map shows the geographic impact of Allison C. Chin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allison C. Chin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allison C. Chin more than expected).

Fields of papers citing papers by Allison C. Chin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allison C. Chin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allison C. Chin. The network helps show where Allison C. Chin may publish in the future.

Co-authorship network of co-authors of Allison C. Chin

This figure shows the co-authorship network connecting the top 25 collaborators of Allison C. Chin. A scholar is included among the top collaborators of Allison C. Chin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allison C. Chin. Allison C. Chin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Role of patient and public involvement in implementation research: a consensus study 2018 ·BMJ Quality & Safety ·Kara Gray‐Burrows, Thomas A. Willis, Robbie Foy, (unknown), (unknown), Allison C. Chin, (unknown), (unknown), Graham Prestwich, (unknown), Laurence Wood, (unknown), Rosemary McEachan	94
2	Cycloastragenol Is a Potent Telomerase Activator in Neuronal Cells: Implications for Depression Management 2014 ·Neurosignals ·Fanny C.F. Ip, Yu Pong Ng, (unknown), (unknown), (unknown), (unknown), Allison C. Chin, Calvin B. Harley, Yung Hou Wong, Nancy Y. Ip	65
3	Astragaloside IV and Cycloastragenol Stimulate the Phosphorylation of Extracellular Signal-Regulated Protein Kinase in Multiple Cell Types 2011 ·Planta Medica ·Lisa Y. Yung, Wing Lam, Maurice K.C. Ho, Yue‐Qing Hu, Fanny C.F. Ip, (unknown), Allison C. Chin, Calvin B. Harley, Nancy Y. Ip, Yung Hou Wong	38
4	In vitro Intestinal Absorption and First-pass Intestinal and Hepatic Metabolism of Cycloastragenol, a Potent Small Molecule Telomerase Activator 2010 ·Drug Metabolism and Pharmacokinetics ·Jing Zhu, Stephanie J. Lee, Maurice K.C. Ho, Yue‐Qing Hu, (unknown), Fanny C.F. Ip, Allison C. Chin, Calvin B. Harley, Nancy Y. Ip, Yung Hou Wong	29
5	Telomerase-Based Pharmacologic Enhancement of Antiviral Function of Human CD8+ T Lymphocytes 2008 ·The Journal of Immunology ·(unknown), Beth D. Jamieson, Allison C. Chin, Ronald T. Mitsuyasu, (unknown), Hwee L. Ng, Christina M. Ramirez, Otto O. Yang, Calvin B. Harley, Rita B. Effros	135
6	GRN163L, a Potent and Specific Inhibitor of Telomerase: Integrated Pharmacokinetic, Pharmacodynamic, and Safety Data Guides Design of Practical Treatment Regimens for Targeting Inhibitory Levels in Patients. 2006 ·Blood ·Robert Tressler, Allison C. Chin, Eric J. Feldman, R. Kanti, Doug Kornbrust, Calvin B. Harley, (unknown), Laurence Elias	2
7	Lipid modification of GRN163, an N3′ → P5′ thio-phosphoramidate oligonucleotide, enhances the potency of telomerase inhibition 2005 ·Oncogene ·Brittney‐Shea Herbert, Ginelle C. Gellert, Amelia E. Hochreiter, Krisztina Pongracz, Woodring E. Wright, Daria Zielińska, Allison C. Chin, Calvin B. Harley, Jerry W. Shay, Sergei Gryaznov	184
8	Telomerase Antagonists GRN163 and GRN163L Inhibit Tumor Growth and Increase Chemosensitivity of Human Hepatoma * 2005 ·Hepatology ·Meta W. Djojosubroto, Allison C. Chin, Ning Go, Sonja Schaetzlein, Michael P. Manns, Sergei Gryaznov, Calvin B. Harley, K. Lenhard Rudolph	111
9	GRN163L Inhibits Telomerase Activity in B-CLL Cells. 2005 ·Blood ·Claudia Qiao Lin, Rajendra N. Damle, Nicholas Chiorazzi, Allison C. Chin	2
10	Telomerase Inhibition, Telomere Shortening and Apoptotic Cell Death in Multiple Myeloma Cells Following Exposure to a Novel and Potent Telomerase Inhibitor (GRN163L), Targeting RNA component of Telomerase. 2004 ·Blood ·Masood A. Shammas, (unknown), (unknown), Pierfrancesco Tassone, Paola Neri, Frank Désarnaud, Allison C. Chin, Sergei Gryaznov, Kenneth C. Anderson, Nikhil C. Munshi	1
11	Oligonucleotide N3′ → P5′ Thio-phosphoramidate Telomerase Template Antagonists as Potential Anticancer Agents 2003 ·Nucleosides Nucleotides & Nucleic Acids ·Sergei Gryaznov, Akira Asai, Yuko Oshima, Yoshihiro Yamamoto, Krisztina Pongracz, (unknown), (unknown), Mieczyslaw A. Piatyszek, Shihong Li, Allison C. Chin, Calvin B. Harley, Shiro Akinaga, Yoshinori Yamashita	23
12	Novel Short Oligonucleotide Conjugates as Inhibitors of Human Telomerase 2003 ·Nucleosides Nucleotides & Nucleic Acids ·Krisztina Pongracz, Shihong Li, Brittney‐Shea Herbert, (unknown), (unknown), Allison C. Chin, Mieczyslaw A. Piatyszek, Jerry W. Shay, Sergei Gryaznov	5
13	A novel telomerase template antagonist (GRN163) as a potential anticancer agent. 2003 ·PubMed ·Akira Asai, Yuko Oshima, Yoshihiro Yamamoto, Takaaki Uochi, Hideaki Kusaka, Shiro Akinaga, Yoshinori Yamashita, Krisztina Pongracz, (unknown), (unknown), Mieczyslaw A. Piatyszek, Shihong Li, Allison C. Chin, Calvin B. Harley, Sergei Gryaznov	189
14	Telomerase inhibition with an oligonucleotide telomerase template antagonist: in vitro and in vivo studies in multiple myeloma and lymphoma 2003 ·Blood ·Eunice S. Wang, Kaida Wu, Allison C. Chin, Selina Chen‐Kiang, Krisztina Pongracz, Sergei Gryaznov, Malcolm A.S. Moore	59
15	Cloning and Functional Promoter Mapping of the Rat Serotonin-2 Receptor Gene 1994 ·Molecular and Cellular Neuroscience ·Steven J. Garlow, Allison C. Chin, Adrian Marinovich, (unknown), Roland D. Ciaranello	11
16	Differential expression of transcripts from syb, a Drosophila melanogaster gene encoding VAMP (synaptobrevin) that is abundant in non-neuronal cells 1993 ·Gene ·Allison C. Chin, Robert W. Burgess, Brian Wong, Thomas L. Schwarz	52
17	Organization and Expression of the Drosophila FMRFamide-Related Prohormone Gene 1990 ·DNA and Cell Biology ·Allison C. Chin, Elaine Reynolds, Richard H. Scheller	49
18	Tse-2: a trans-Dominant Extinguisher of Albumin Gene Expression in Hepatoma Hybrid Cells 1989 ·Molecular and Cellular Biology ·Allison C. Chin, R. E. K. Fournier	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact